ArticleBlood advances2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey.
Abstract read
In one paragraph
Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- 30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Annals of hematology · 2026Review
- Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.American journal of hematology · 2025Article
- COVID-19 vaccination in patients with classic and variant hairy cell leukemia.Blood neoplasia · 2024Article
- Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.Infection · 2024Article
- Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.EClinicalMedicine · 2024Article
- COVID-19 in patients with classic and variant hairy cell leukemia.Blood advances · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Sylvain LamureDepartment of Clinical Hematology, Montpellier University Hospital, IGMM UMR5535 Centre National de la Recherche Scientifique (CNRS), University of Montpellier, Montpellier, France.ORCID 0000-0001-5980-305X
Jon Salmanton-GarcíaFaculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.ORCID 0000-0002-6766-8297
Elena Robin-MarietonService d'Hématologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France.
Ozren JaksicUniversity Hospital Dubrava, Zagreb, Croatia.ORCID 0000-0003-4026-285X
Milena KohnService d'Hématologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France.
Francesco MarchesiHematology and Stem Cell Transplant Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.ORCID 0000-0001-6353-2272
Monia MarchettiAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.ORCID 0000-0001-7615-0572
Shaimaa El-AshwahOncology Center, Mansoura University, Mansoura, Egypt.ORCID 0000-0003-2210-1534
Fatih DemirkanDivision of Hematology, Dokuz Eylul University, Izmir, Turkey.ORCID 0000-0002-1172-8668
Toni ValkovićUniversity Hospital Centre Rijeka, and Croatian Cooperative Group for Hematological Diseases (CROHEM), Faculty of Medicine and Faculty of Health Studies University of Rijeka, Rijeka, Croatia.ORCID 0000-0001-6083-8815
Noemí FernándezHospital Universitario Marqués de Valdecilla, Santander, Spain.
Maria Chiara TisiDepartment of Hematology, Ospedale San Bortolo, Vicenza, Italy.ORCID 0000-0001-8231-6700
Zlate StojanoskiUniversity Clinic of Hematology, Skopje, Republic of North Macedonia.ORCID 0000-0001-7502-8356
Guldane Cengiz SevalDepartment of Hematology, Ankara University School of Medicine, Ankara, Turkey.ORCID 0000-0001-9433-2054
Osman IlhanDepartment of Hematology, Ankara University School of Medicine, Ankara, Turkey.
Lucia PreziosoHematology and Bone Marrow Unit, University of Parma Hospital, Parma, Italy.ORCID 0000-0003-1660-4960
Maria MerelliAzienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy.ORCID 0000-0003-3352-1163
Alberto López-GarcíaFundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-5354-5261
Marie-Pierre LedouxInstitut de Cancérologie de Strasbourg Europe, Strasbourg, France.ORCID 0000-0002-3261-3616
Austin KulasekararajKing's College Hospital, London, United Kingdom.ORCID 0000-0003-3180-3570
Tomás-José González-LópezDepartment of Hematology, Hospital Universitario de Burgos, Burgos, Spain.
Maria Gomes da SilvaDepartamento de Hematologia, Instituto Português de Oncologia, Lisboa, Portugal.ORCID 0000-0002-6993-2450
Ziad EmarahOncology Center, Mansoura University, Mansoura, Egypt.ORCID 0000-0003-0622-2598
Rafael F DuarteHospital Universitario Puerta de Hierro, Majadahonda, Spain.ORCID 0000-0002-5240-9815
Chiara CattaneoHematology Unit, ASST-Spedali Civili, Brescia, Italy.ORCID 0000-0003-0031-3237
Ola BlennowDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-7167-7882
Yavuz M BilginDepartment of Internal Medicine, Adrz, Goes, The Netherlands.ORCID 0000-0003-4854-5424
Rui BergantimCentro Hospitalar e Universitário São João, Porto, Portugal.ORCID 0000-0002-7811-9509
Josip BatinićSchool of Medicine, University of Zagreb, and Croatian Cooperative Group for Hematological Diseases (CROHEM), Zagreb, Croatia.ORCID 0000-0001-5595-9911
Raul CordobaHealth Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain.ORCID 0000-0002-7654-8836
Jenna EssameKing's College Hospital, London, United Kingdom.ORCID 0000-0003-0926-5577
Anna NordlanderDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Raquel Nunes RodriguesDepartamento de Hematologia, Instituto Português de Oncologia, Lisboa, Portugal.ORCID 0000-0002-8347-4281
Maria Vittoria SacchiAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.ORCID 0000-0001-8133-3357
Sofia ZompiStem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy.ORCID 0000-0002-4075-8727
Alessandro BuscaStem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy.ORCID 0000-0001-5361-5613
Paolo CorradiniUniversity of Milan and Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.ORCID 0000-0002-9186-1353
Martin HoeniglDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, and Clinical and Translational Fungal Research-Working Group, University of California San Diego, La Jolla, CA, and Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-1653-2824
Nikolai KlimkoNorth-Western State Medical University named after Iliá Ilich Méchnikov, Saint-Petersburg, Russia.ORCID 0000-0001-6095-7531
Philipp KoehlerFaculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.ORCID 0000-0002-7386-7495
Antonio PagliucaDepartment of Hematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom.ORCID 0000-0003-2519-0333
Francesco PassamontiDepartment of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy.ORCID 0000-0001-8068-5289
Rémy DuléryService d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne University, INSERM UMRS 938, Paris, France, Faculty of Medicine, University of Cologne, and Department I of Internal Medicine, University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.ORCID 0000-0002-5024-1713
Oliver A CornelyFaculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.ORCID 0000-0001-9599-3137
Caroline BessonService d'Hématologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France, Université Paris-Saclay, UVSQ, INSERM, Équipe Exposome et Hérédité, CESP, Villejuif, France; and.ORCID 0000-0003-4364-7173
Livio PaganoHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy, Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0001-8287-928X
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Leukemia, Hairy CellHumans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.